ctrl K

Watchlist Price Alert

Aura Biosciences Inc. (AURA)

NASDAQ: AURA · Real-Time Price · USD

6.03

0.04 (0.67%)

At close: May 28, 2025, 3:33 PM

Aura Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	1.22M	1.29M	1.18M	835K	831K	509K
Gross Profit	n/a	-1.29M	-1.18M	-835K	-831K	-509K
Operating Income	-96.12M	-84.99M	-60.3M	-35.25M	-22.21M	-24.14M
Interest Income	n/a	n/a	1.86M	13K	3.00	5.00
Pretax Income	-86.81M	-76.27M	-58.76M	-35.25M	-22.21M	-24.2M
Net Income	-86.92M	-76.41M	-57.23M	-34.42M	-22.21M	-24.2M
Selling & General & Admin	22.81M	19.76M	18.06M	10.09M	4.16M	4.52M
Research & Development	73.3M	63.94M	42.24M	25.16M	18.04M	19.62M
Other Expenses	n/a	n/a	-5K	-11K	3K	-44K
Operating Expenses	96.12M	84.99M	60.3M	35.25M	22.21M	24.14M
Interest Expense	n/a	n/a	n/a	13K	3K	5K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	-96.12M	84.99M	60.3M	35.25M	22.21M	24.14M
Income Tax Expense	112K	137K	-1.53M	-830K	3K	5K
Shares Outstanding (Basic)	49.65M	39.62M	29.94M	29.21M	29.22M	29.22M
Shares Outstanding (Diluted)	49.65M	39.62M	29.94M	29.21M	29.22M	29.22M
EPS (Basic)	-1.75	-1.93	-1.91	-1.18	-0.76	-0.83
EPS (Diluted)	-1.75	-1.93	-1.91	-1.18	-0.76	-0.83
EBITDA	-85.58M	-83.7M	-59.12M	-34.42M	-21.38M	-23.63M
EBIT	-86.81M	-84.99M	-60.3M	-35.25M	-22.21M	-24.14M
Depreciation & Amortization	1.22M	1.29M	1.18M	835K	831K	509K